NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma

被引:113
|
作者
Cheng, Jun [1 ,2 ]
Xie, Hai-Yang [1 ,2 ]
Xu, Xiao [1 ]
Wu, Jian [1 ]
Wei, Xuyong [2 ]
Su, Rong [2 ]
Zhang, Wu [2 ]
Lv, Zhen [2 ]
Zheng, Shusen [1 ,2 ]
Zhou, Lin [1 ,2 ]
机构
[1] Zhejiang Univ, Div Hepatobiliary & Pancreat Surg, Dept Surg, Affiliated Hosp 1,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China
关键词
Hepatocellular carcinoma; NDRG1; Biomarker; Recurrence; Metastasis; DOWNSTREAM REGULATED GENE-1; SUPPRESSOR GENE; CANCER; EXPRESSION; GROWTH; OVEREXPRESSION; ACTIVATION; INVASION; CELLS;
D O I
10.1016/j.canlet.2011.06.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
N-myc downstream-regulated gene 1 (NDRG1) has been reported to be a multifunctional protein associated with carcinogenesis, however, the cellular function of NDRG1 remains elusive in human cancers. Here, our proteomics profile analysis of HCC tissues with different metastatic capabilities revealed that NDRG1 was correlated with metastasis and recurrence in HCC patients after liver transplantation (LT). Immunohistochemical staining of 143 HCC patients after LT showed that NDRG1-positive expression had poor prognosis, either for shorter disease-free survival or overall survival (P < 0.001), compared with NDRG1-negative expression. Multivariate analysis confirmed NDRG1 as an independent prognostic value (P < 0.001). In addition, in vitro experiments HCC cells with small interfering RNA against NDRG1 significantly suppressed its proliferation, colony formation, invasion and migration ability. Microarray analysis revealed that NDRG1 modulated the expression of genes associated with transmembrane transporter activity, chemoattractant activity, immune response, cell adhesion and cell proliferation process. Taken together, these results suggested that NDRG1 was an important molecule in controlling HCC metastasis and thus suggested as a novel biomarker for predicting HCC recurrence after LT. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:35 / 45
页数:11
相关论文
共 50 条
  • [1] Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma
    Chua, Mei-Sze
    Sun, Hongbo
    Cheung, Siu T.
    Mason, Veronica
    Higgins, John
    Ross, Douglas T.
    Fan, Sheung T.
    So, Samuel
    MODERN PATHOLOGY, 2007, 20 (01) : 76 - 83
  • [2] Overexpression of NDRG1 leads to poor prognosis in hepatocellular carcinoma through mediating immune infiltration and EMT
    Wang, Xiao
    Sun, Ran
    Che, Na
    Zhang, Danfang
    Li, Yanlei
    Zhao, Nan
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (08) : 1382 - 1399
  • [3] NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis
    Joshi, Vaibhavi
    Stacey, Andrew
    Feng, Yufan
    Kalita-de Croft, Priyakshi
    Duijf, Pascal H. G.
    Simpson, Peter T.
    Lakhani, Sunil R.
    Reed, Amy E. McCart
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2024, 10 (02):
  • [4] Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients
    Matsushita, Kohei
    Uchida, Keiichi
    Saigusa, Susumu
    Ide, Shozo
    Hashimoto, Kiyoshi
    Koike, Yuhki
    Otake, Kohei
    Inoue, Mikihiro
    Tanaka, Koji
    Kusunoki, Masato
    PEDIATRIC SURGERY INTERNATIONAL, 2013, 29 (04) : 363 - 368
  • [5] NDRG1 alleviates Erastin-induced ferroptosis of hepatocellular carcinoma
    Li, Liuzheng
    Wu, Tong
    Gong, Guocha
    Li, Bo
    Feng, Jiawei
    Xu, Leisheng
    Zhao, Hairong
    Gao, Xuechang
    BMC CANCER, 2025, 25 (01)
  • [6] Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients
    Kohei Matsushita
    Keiichi Uchida
    Susumu Saigusa
    Shozo Ide
    Kiyoshi Hashimoto
    Yuhki Koike
    Kohei Otake
    Mikihiro Inoue
    Koji Tanaka
    Masato Kusunoki
    Pediatric Surgery International, 2013, 29 : 363 - 368
  • [7] Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
    Xu, Shaohua
    Gao, Ruihuan
    Zhou, Yidan
    Yang, Ying
    Zhang, Yi
    Li, Qianyuan
    Luo, Chunhua
    Liu, Song-Mei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity
    Dang, Hao
    Chen, Ling
    Tang, Ping
    Cai, Xuefei
    Zhang, Wenlu
    Zhang, Renfei
    Huang, Ailong
    Tang, Hua
    CELLULAR ONCOLOGY, 2020, 43 (05) : 931 - 947
  • [9] Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma
    Ando, T.
    Ishiguro, H.
    Kimura, M.
    Mitsui, A.
    Kurehara, H.
    Sugito, N.
    Tomoda, K.
    Mori, R.
    Takashima, N.
    Ogawa, R.
    Fujii, Y.
    Kuwabara, Y.
    DISEASES OF THE ESOPHAGUS, 2006, 19 (06): : 454 - 458
  • [10] Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma
    Ando, Takuya
    Ishiguro, Hideyuki
    Kuwabara, Yoshiyuki
    Kimura, Masahiro
    Mitsui, Akira
    Kurehara, Hiroki
    Sugito, Nobuyoshi
    Takashima, Nobuhiro
    Fujii, Yoshitaka
    CANCER RESEARCH, 2006, 66 (08)